TI
COLL icon

Trexquant Investment’s Collegium Pharmaceutical COLL Stock Holding History

Trexquant Investment’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-68,114
Closed -$2.25M – 1940
2026
Q1 		$2.25M Sell
68,114
-82,488
-55% -$3.49M 0.02% 951
2025
Q4 		$6.97M Buy
+150,602
New +$6.3M 0.06% 435
2024
Q3 		– Sell
-15,806
Closed -$509K – 1570
2024
Q2 		$509K Sell
15,806
-92,421
-85% -$3.2M 0.01% 1242
2024
Q1 		$4.2M Buy
108,227
+13,650
+14% +$478K 0.08% 370
2023
Q4 		$2.91M Sell
94,577
-38,402
-29% -$962K 0.07% 432
2023
Q3 		$2.97M Buy
132,979
+32,680
+33% +$745K 0.07% 370
2023
Q2 		$2.16M Sell
100,299
-15,428
-13% -$350K 0.06% 472
2023
Q1 		$2.78M Buy
115,727
+105,323
+1,012% +$2.79M 0.08% 349
2022
Q4 		$241K Buy
+10,404
New +$210K 0.01% 1177
2021
Q4 		– Sell
-18,549
Closed -$366K – 1348
2021
Q3 		$366K Buy
+18,549
New +$401K 0.03% 660
2021
Q2 		– Sell
-20,174
Closed -$478K – 1147
2021
Q1 		$478K Buy
+20,174
New +$479K 0.04% 527
2019
Q3 		– Sell
-11,316
Closed -$149K – 895
2019
Q2 		$149K Sell
11,316
-18,669
-62% -$250K 0.01% 714
2019
Q1 		$454K Sell
29,985
-3,096
-9% -$49.6K 0.03% 606
2018
Q4 		$568K Sell
33,081
-1,111
-3% -$19K 0.04% 577
2018
Q3 		$504K Buy
+34,192
New +$606K 0.04% 536
2018
Q2 		– Sell
-23,534
Closed -$601K – 945
2018
Q1 		$601K Buy
+23,534
New +$561K 0.04% 579
2017
Q2 		– Sell
-25,705
Closed -$259K – 837
2017
Q1 		$259K Buy
+25,705
New +$382K 0.03% 835

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Trexquant Investment's COLL Position: Q2 2026 in Review

Trexquant Investment sold out of Collegium Pharmaceutical (COLL) in Q2 2026, closing a stake of 68,114 shares — an estimated $2.25M sold.

Trexquant Investment first reported a position in COLL in Q1 2017 and held it in 17 quarters. The position peaked at $6.97M in Q4 2025. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Trexquant Investment reported no remaining Collegium Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 68,114 Collegium Pharmaceutical shares in Q2 2026, an estimated $2.25M.
  • Trexquant Investment first reported a position in Collegium Pharmaceutical in Q1 2017 and held it in 17 quarters.
  • Trexquant Investment's Collegium Pharmaceutical position peaked at $6.97M in Q4 2025.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.